Actively hiring
Biologics & Biosimilars
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Overview
From rare antibodies to innovative therapeutics. BliNK Biomedical's powerful B cell technology enables the selection and isolation of specific antibody producing cells for difficult targets from B cells of many species, such as man, mouse, rabbit, dog, etc.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Financials
Est. Annual Revenue
$282k
2025
